Clinical Trial Update: An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Schizophrenia [Phase 3]

View source ↗

Summary

Extension study results for a second course of a digital therapeutic targeting experiential negative symptoms in schizophrenia, completed Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Negative Symptoms in Schizophrenia
• Schizophrenia

Drugs mentioned

• Click Therapy Digital Therapeutic

Snippet

Sponsor: Click Therapeutics, Inc. | Conditions: Schizophrenia, Negative Symptoms in Schizophrenia | Phase 3 | Status: COMPLETED